On-demand Webinar
In recent years, mammalian synthetic biology has made significant strides, especially in controlling gene expression and designing complex cellular behaviors. Researchers have now begun to apply these principles at the protein level as well, enhancing control over secreted protein components.
Join us in this webinar case study to discover how using the right technology, scientists can progress their work and iterate in ways that were previously unimaginable. We’ll explore:
- How to effectively enable synergistic strategies with engineerable regulation across multiple levels of the central dogma
- An exciting look at innovative platforms, such as the Retained Endoplasmic Cleavable Secretion (RELEASE) platform developed by Stanford’s Gao Lab
- The next-generation applications for re-wiring intercellular communication
- What impact current transformations will have on cancer biology, immunology, and neuroscience
- Advanced cloning techniques, with a look at the novel methods delivering efficient, reliable, and customizable DNA synthesis
- And more
Ansa Biotechnologies was founded by scientists specifically to address the needs of customers like the Gao Lab. By developing a novel enzymatic synthesis method to contiguously synthesize 600 bp, the company can build nearly any sequence quickly, reliably and efficiently, even those rejected by other vendors.
Speakers
Dan Lin-Arlow
Cofounder and CSO
Ansa Biotechnologies
Connor Clayton Call
Graduate Student
Gao Lab, Stanford University